Acadian Asset Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-12,734
Closed -$271K 2038
2022
Q4
$271K Buy
+12,734
New +$272K ﹤0.01% 1213
2021
Q1
Sell
-56,980
Closed -$394K 2389
2020
Q4
$394K Sell
56,980
-454,745
-89% -$2.91M ﹤0.01% 1302
2020
Q3
$2.89M Sell
511,725
-436,567
-46% -$2.08M 0.01% 569
2020
Q2
$4.84M Buy
948,292
+38,916
+4% +$162K 0.02% 498
2020
Q1
$3.13M Buy
909,376
+19,832
+2% +$116K 0.02% 483
2019
Q4
$7.63M Sell
889,544
-350,783
-28% -$1.25M 0.03% 362
2019
Q3
$1.39M Sell
1,240,327
-20,078
-2% -$23.4K 0.01% 797
2019
Q2
$1.64M Buy
1,260,405
+84,931
+7% +$117K 0.01% 674
2019
Q1
$1.66M Buy
1,175,474
+84,127
+8% +$118K 0.01% 733
2018
Q4
$1.31M Sell
1,091,347
-125,208
-10% -$243K 0.01% 667
2018
Q3
$2.87M Buy
1,216,555
+52,287
+4% +$130K 0.01% 484
2018
Q2
$3.18M Buy
1,164,268
+452,127
+63% +$1.25M 0.01% 459
2018
Q1
$1.95M Buy
712,141
+512,733
+257% +$1.49M 0.01% 592
2017
Q4
$622K Buy
+199,408
New +$561K ﹤0.01% 769
2017
Q3
Sell
-14,058
Closed -$36K 1575
2017
Q2
$36K Sell
14,058
-575,277
-98% -$1.57M ﹤0.01% 1179
2017
Q1
$2.16M Buy
+589,335
New +$2.49M 0.01% 596
2015
Q3
Sell
-2,382
Closed -$124K 1471
2015
Q2
$124K Buy
+2,382
New +$118K ﹤0.01% 986
2015
Q1
Sell
-2,654
Closed -$119K 1492
2014
Q4
$119K Buy
+2,654
New +$111K ﹤0.01% 973

Other funds holding ISEE

Acadian Asset Management's ISEE Position: Q1 2023 in Review

Acadian Asset Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2023, closing a stake of 12,734 shares — an estimated $271K sold.

Acadian Asset Management first reported a position in ISEE in Q4 2014 and held it in 18 quarters. The position peaked at $7.63M in Q4 2019. 223 funds tracked by Wall St. Rank hold ISEE as of Q1 2023.

  • Acadian Asset Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Acadian Asset Management sold 12,734 IVERIC bio, Inc. Common Stock shares in Q1 2023, an estimated $271K.
  • Acadian Asset Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2014 and held it in 18 quarters.
  • Acadian Asset Management's IVERIC bio, Inc. Common Stock position peaked at $7.63M in Q4 2019.
  • 223 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2023.

Based on Acadian Asset Management's 13F filing for Q1 2023, filed 11 May 2023.